Table 1.
Virus nanoparticles employed in biomedicine
| VIRUS (short name) | Symmetry | Size (nm) | Application in biomedicine | References | ||
|---|---|---|---|---|---|---|
| Outer | Inner | |||||
| Plant viruses | Cowpea Chlorotic Mottle Virus (CCMV) | Icosahedral | 28 | 18 | Biocompatible nanoplatforms | [104] |
| Cowpea Mosaic Virus (CPMV) | Icosahedral | 28 | 20 | Doxorubicin delivery | [101] | |
| Red Clover Necrotic Mosaic Virus (RCNMV) | Icosahedral | 35 | 17 | Multifunctional cell targeting VNP | [102] | |
| Animal viruses | Adenovirus | icosahedral | 90 | 62 | Anticancer bleomycin (BLM) delivery | [107] |
| Simian virus 40 (SV40) | icosahedral | 50 | 36 | Nanoplatform for therapeutic use | [106] | |
| Polyomavirus (JCV) | Icosahedral | 45 | 32 | Drug‐releasing VNP | [106] | |
| Bacteriophages | MS2 | Icosahedral | 27 | 21 | RNA, DNA‐based drugs delivery | [108] |
| P22 | Icosahedral | 64 | 54 | Nanoscale MRI contrast agent | [109] | |
| Qβ | Icosahedral | 27 | 21 | Imaging agents delivery | [110] | |
| M13 | Helical | 6.6 × 880 | — | Convection‐enhanced delivery | [111] | |